The foundational Lustre recovery protocol. CJC-1295 + Ipamorelin work synergistically to support natural growth hormone pulsatility — helping improve sleep quality, recovery capacity, and overnight cellular repair.
CJC-1295 (a long-acting GHRH analogue) paired with Ipamorelin (a selective ghrelin receptor agonist) works together to support natural growth hormone pulsatility. Unlike direct HGH, this protocol signals your pituitary to release growth hormone in physiologic pulses — aligning more closely with the body’s natural rhythm.
Administered in the evening, CJC-1295 + Ipamorelin support the body’s natural overnight growth hormone pulse. This pulse is closely tied to deep sleep stages and plays a key role in recovery, tissue repair, metabolic regulation, and overall regenerative balance. As GH signaling normalizes, patients typically notice improved sleep depth within weeks, followed by gradual improvements in recovery, energy, and body composition over 3–6 months.
Women experiencing declining energy, disrupted sleep, slower recovery, or the general sense that the body is not restoring itself the way it used to. An ideal entry point into peptide therapy.
Most patients report noticeable improvements in sleep depth and morning energy within 2–4 weeks. The full range of benefits — including skin and body composition changes — becomes apparent over 3–6 months.
No — and the distinction matters. CJC-1295 + Ipamorelin stimulate natural growth hormone release through complementary pathways rather than introducing synthetic HGH. This preserves physiologic feedback signaling and supports a more natural pulsatile pattern of GH secretion.
Your provider will typically request baseline IGF-1 levels before prescribing CJC-1295 + Ipamorelin. We order labs to your nearest LabCorp or you can upload a recent panel from your physician.
Yes — The Recovery Protocol (CJC-1295 + Ipamorelin) and The Glow Protocol are one of the most common stacks at Lustre. Your provider will advise on optimal timing and dosing for the combination.
Compounded peptides are prescribed off-label for wellness, performance, and recovery goals under the supervision of a licensed medical provider. They are not intended to diagnose, treat, cure, or prevent any disease.
All peptides dispensed by Lustre Health are prescription-only medications requiring a valid prescription from a licensed provider.
Compounded medications are not FDA-approved drug products. They are prepared by state-licensed 503A compounding pharmacies under USP Chapter 797 standards.
Peptides may interact with insulin, hormone therapies, and immunosuppressants. Disclose all medications to your provider.
Subcutaneous injection. Full training provided with your first shipment.